NEWPORT BEACH, CA, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - ADVANTIS CORPORATION (OTC PINK: ADVT) provided additional details about its sublingual tabs today, and revealed a proprietary process for med delivery. As the company announces its immediate, measurable dosage delivery system, the company announced that it is completing its first orders of edible packaging and Amster-Can revenue is set to double.
According to Advantis CEO, Darren Cherry, the sublingual tabs will be faster acting that what is currently in the market. “Edibles and sublinguals generally take thirty to sixty minutes to take effect,” Cherry explained. “Many edibles can be more unpredictable depending on a person’s metabolism, and the amount of THC and CBD is sometimes not consistent; this makes it difficult to measure a precise dose. We have solved that problem.” Cherry explained that the new substance delivery process will start becoming effective within two to three minutes, as opposed to the unpredictable time until efficacy with edibles and other sublingual tabs. “In addition to the delivery system, we will have precise measurements of THC, CBD, or a combination of both available in different strengths. The process is made possible by a new partnership we are cementing with a Canadian manufacturing company.” Cherry says they are set to ink a deal with its Oregonian partner to manufacture and distribute the formula with the proprietary delivery system, and Advantis has a ready-made client base in California waiting for the tabs to arrive. The unnamed Canadian company will supply the medium and Advantis or its partners will infuse it with the exact amount of THC and/or CBD to make its end products. “We have a budding partnership in the works and can’t wait to bring these tabs to market,” Cherry said. “Testing is underway.”
Last week Cherry announced that the company had begun packaging edibles as well as flowers and extracts. Today, he announced that the first pallet-size orders are nearing completion this week. “The immediate demand has been amazing,” Cherry stated. “In the beginning, we were happy to go through a pallet every two to three months, today, we can go through a pallet in a week, thanks to the addition of edibles to our packaging lineup.” Cherry says that he has already ordered additional pallets for the sharp increase in demand resulting directly from the debut of edible packaging last week. “The decision to package edibles is a home run. Based on current orders, this will double Amster-Can production in the coming months, and the sublingual tabs are almost ready to go. Each new product we introduce results in a brand new scalable revenue stream to add to our bottom line,” Cherry concluded.
Advantis wishes to thank Investors Hangout for mentioning the company in their podcast.
Links to Advantis pictures and websites can be found on Facebook and Instagram pages, and at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com.
About Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services.
Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.